These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7265809)

  • 41. Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy.
    Brewer GJ; Johnson VD; Dick RD; Hedera P; Fink JK; Kluin KJ
    Hepatology; 2000 Feb; 31(2):364-70. PubMed ID: 10655259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methods for assaying D-penicillamine in a clinical setting.
    Crawhall JC
    Clin Invest Med; 1984; 7(1):31-4. PubMed ID: 6723121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
    Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT
    Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Teratogen update: penicillamine.
    Rosa FW
    Teratology; 1986 Feb; 33(1):127-31. PubMed ID: 3738805
    [No Abstract]   [Full Text] [Related]  

  • 45. Copper and taste sensitivity.
    Nutr Rev; 1968 Jun; 26(6):175-7. PubMed ID: 4874926
    [No Abstract]   [Full Text] [Related]  

  • 46. [Pregnancy and Wilson's disease: safety of penicillamine use].
    Miranda M; Villagar R
    Rev Med Chil; 1997 Apr; 125(4):497-8. PubMed ID: 9460294
    [No Abstract]   [Full Text] [Related]  

  • 47. [The detection of antibodies against D-penicillamine. 3. Detection of antibodies against D-penicillamine in the serum of patients with Wilson's disease treated with D-penicillamine--preliminary results].
    Trautmann B; Storch W
    Pharmazie; 1986 Feb; 41(2):126-7. PubMed ID: 3523546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Nephrotic syndrome after treatment with penicillamine in Wilson's disease].
    Hampel R; Meng W; Kallwellis G
    Z Gesamte Inn Med; 1976 Jul; 31(13):507-11. PubMed ID: 960872
    [TBL] [Abstract][Full Text] [Related]  

  • 49. D-Penicillamine--induced pemphigus syndrome.
    Yung CW; Hambrick GW
    J Am Acad Dermatol; 1982 Mar; 6(3):317-24. PubMed ID: 7068961
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Therapeutic problems during D-penicillamine treatment of patients with cystine calculi].
    Wenzl H; Kludas M
    Munch Med Wochenschr; 1970 Nov; 112(48):2187-90. PubMed ID: 5536878
    [No Abstract]   [Full Text] [Related]  

  • 51. Pregnancy Outcomes in Wilson's Disease Women: Single-Center Case Series.
    Mussi MCL; Nardelli MJ; Santos BC; Abreu ES; Osório FMF; Cançado GGL; Ferrari TCA; Faria LC; Couto CA
    Fetal Pediatr Pathol; 2022 Oct; 41(5):741-748. PubMed ID: 34350816
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Immunologic studies with the lymphocyte transformation test on the side effects of D-penicillamine therapy in Wilson's disease].
    Storch W; Berger H
    Z Gesamte Inn Med; 1980 Jul; 35(13):567-70. PubMed ID: 7445606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epileptic status immediately after initiation of D-penicillamine therapy in a patient with Wilson's disease.
    Berger B; Mader I; Damjanovic K; Niesen WD; Stich O
    Clin Neurol Neurosurg; 2014 Dec; 127():122-4. PubMed ID: 25459257
    [No Abstract]   [Full Text] [Related]  

  • 54. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
    Germinario L; Campanella G; D'Addabbo A
    Acta Neurol (Napoli); 1971; 26(4):423-35. PubMed ID: 5132824
    [No Abstract]   [Full Text] [Related]  

  • 56. Penicillamine associated pulmonary hemorrhage.
    Louie S; Gamble CN; Cross CE
    J Rheumatol; 1986 Oct; 13(5):963-6. PubMed ID: 3820209
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elastosis perforans serpiginosa secondary to D-penicillamine therapy with coexisting cutis laxa.
    Rosen LB; Muellenhoff M; Tran TT; Muhart M
    Cutis; 2005 Jul; 76(1):49-53. PubMed ID: 16144289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Systemic lupus erythematosus induced by d-penicillamine in Wilson's disease: apropos of a case].
    López-Guerra N; Alvarez Lario B; García-Moncó C; Peña Sagredo JL
    Med Clin (Barc); 1987 Apr; 88(13):552-4. PubMed ID: 3586738
    [No Abstract]   [Full Text] [Related]  

  • 59. [An unusual cutaneous reaction pattern as a side effect of penicillamine: elastosis perforans serpiginosa].
    van Joost T; de Leeuw J
    Ned Tijdschr Geneeskd; 1988 Mar; 132(11):501-3. PubMed ID: 2965796
    [No Abstract]   [Full Text] [Related]  

  • 60. Reversible cutis laxa due to maternal D-penicillamine treatment.
    Linares A; Zarranz JJ; Rodriguez-Alarcon J; Diaz-Perez JL
    Lancet; 1979 Jul; 2(8132):43. PubMed ID: 87922
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.